These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 16799207

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
    Gualco G, Weiss LM, Barber GN, Bacchi CE.
    Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Large B-cell lymphoma with Hodgkin's features.
    García JF, Mollejo M, Fraga M, Forteza J, Muniesa JA, Pérez-Guillermo M, Pérez-Seoane C, Rivera T, Ortega P, Piris MA.
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathologic analysis of CD10+ and CD10- diffuse large B-cell lymphoma. Identification of a high-risk subset with coexpression of CD10 and bcl-2.
    Xu Y, McKenna RW, Molberg KH, Kroft SH.
    Am J Clin Pathol; 2001 Aug; 116(2):183-90. PubMed ID: 11488064
    [Abstract] [Full Text] [Related]

  • 6. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A, Rüdiger T, Marx A, Müller-Hermelink HK, Ott G.
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of BCL-2, BCL-X, and BAX in primary central nervous system lymphomas that occur in immunosuppressed patients.
    Camilleri-Broët S, Camparo P, Mokhtari K, Hoang-Xuan KH, Martin A, Arborio M, Hauw JJ, Raphaël M.
    Mod Pathol; 2000 Feb; 13(2):158-65. PubMed ID: 10697273
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
    Sohn SK, Jung JT, Kim DH, Kim JG, Kwak EK, Park Ti, Shin DG, Sohn KR, Lee KB.
    Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
    [Abstract] [Full Text] [Related]

  • 9. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma.
    Yegappan S, Coupland R, Arber DA, Wang N, Miocinovic R, Tubbs RR, Hsi ED.
    Mod Pathol; 2001 Nov; 14(11):1147-56. PubMed ID: 11706077
    [Abstract] [Full Text] [Related]

  • 10. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
    Ree HJ, Yang WI, Kim CW, Huh J, Lee SS, Cho EY, Ko YH, Charney D.
    Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT, Fernandes BJ, Mock D.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [Abstract] [Full Text] [Related]

  • 12. [Bcl-2 in potentials precursors of nodular paragranuloma and its dedifferentiated variant (large cell B-lymphoma)].
    Lorenzen J, Hansmann ML, Shibata D, Hell K, Klöckner A, Pezzella F, Fischer R.
    Verh Dtsch Ges Pathol; 1992 Aug; 76():169-72. PubMed ID: 1283252
    [Abstract] [Full Text] [Related]

  • 13. CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma.
    Fang JM, Finn WG, Hussong JW, Goolsby CL, Cubbon AR, Variakojis D.
    Mod Pathol; 1999 Mar; 12(3):295-300. PubMed ID: 10102615
    [Abstract] [Full Text] [Related]

  • 14. CD23 expression in mediastinal large B-cell lymphomas.
    Calaminici M, Piper K, Lee AM, Norton AJ.
    Histopathology; 2004 Dec; 45(6):619-24. PubMed ID: 15569053
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
    Muris JJ, Meijer CJ, Vos W, van Krieken JH, Jiwa NM, Ossenkoppele GJ, Oudejans JJ.
    J Pathol; 2006 Apr; 208(5):714-23. PubMed ID: 16400625
    [Abstract] [Full Text] [Related]

  • 16. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
    Nakamura N, Nakamine H, Tamaru J, Nakamura S, Yoshino T, Ohshima K, Abe M.
    Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of inflammatory cytokines at diagnosis correlate to the bcl-6 and CD10 defined germinal centre (GC) phenotype and bcl-2 expression in patients with diffuse large B-cell lymphoma.
    Pedersen LM, Jürgensen GW, Johnsen HE.
    Br J Haematol; 2005 Mar; 128(6):813-9. PubMed ID: 15755285
    [Abstract] [Full Text] [Related]

  • 18. Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma.
    Frost M, Newell J, Lones MA, Tripp SR, Cairo MS, Perkins SL.
    Am J Clin Pathol; 2004 Mar; 121(3):384-92. PubMed ID: 15023043
    [Abstract] [Full Text] [Related]

  • 19. Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas.
    Bairey O, Zimra Y, Shaklai M, Okon E, Rabizadeh E.
    Clin Cancer Res; 1999 Oct; 5(10):2860-6. PubMed ID: 10537354
    [Abstract] [Full Text] [Related]

  • 20. [Histological and immunohistochemical characteristics of diffuse large cell B-cell lymphomas].
    Krivolapov IuA, Saltykova LB, Kozlova AA.
    Arkh Patol; 2000 Oct; 62(6):19-24. PubMed ID: 11198116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.